JOHN KIRKWOOD to Receptors, Fibroblast Growth Factor
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Receptors, Fibroblast Growth Factor.
Connection Strength
0.388
-
Phase I/II and pharmacodynamic study of dovitinib (TKI258), an inhibitor of fibroblast growth factor receptors and VEGF receptors, in patients with advanced melanoma. Clin Cancer Res. 2011 Dec 01; 17(23):7451-61.
Score: 0.379
-
Molecular analysis of melanoma precursor lesions. Cell Growth Differ. 1996 Dec; 7(12):1733-40.
Score: 0.008